date,title,source
Oct-31-18,Savara Completes Enrollment in Molgradex OPTIMA Clinical Study for the Treatment of NTM,GlobeNewswire
Nov-01-18,"Savara to Host Third Quarter 2018 Financial Results and Business Update Conference Call on November 7, 2018",GlobeNewswire
Nov-16-18,"Savara to Present at the Evercore ISI HealthCONx Conference on Tuesday, November 27th",GlobeNewswire
Dec-19-18,Savara Announces Interim Results for OPTIMA Clinical Study of Molgradex for the Treatment of NTM,GlobeNewswire
Jan-16-19,Could The Savara Inc. (NASDAQ:SVRA) Ownership Structure Tell Us Something Useful?,Simply Wall St.
Feb-06-19,Savara Provides Update on IMPALA and AVAIL Pivotal Clinical Studies,GlobeNewswire
